ADC Therapeutics SA’s $30.6 Million Shares Offering

Homburger advises ADC Therapeutics SA in its follow-on public offering in the United States. Lenz & Staehelin advised the underwriters on the Swiss law aspects of…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Paolo Bossi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here